Curcumin-Modified Selenium Nanoparticles Improve S180 Tumour Therapy in Mice by Regulating the Gut Microbiota and Chemotherapy [Corrigendum]
Abstract
Zhang R, Zhang W, Zhang Q, et al. Int J Nanomedicine. 2024;19:13653–13669. https://doi.org/10.2147/IJN.S476686 The authors have advised that Figure 5E on page 13664 was mistakenly copied from the control group causing the HE staining image of the heart in the Cur/Se NPs group to be duplicated. The correct Figure 5 is shown below. Figure 5 Anti-S180 tumour study in vivo. (a) S180 tumour growth curves. (b) Body weight curves. (c) Photograph of excised tumours. (d) Excised tumour weights on Day 10. (e) HE staining of the organs. The results are expressed as the means ± SDs (n = 6). *P < 0.05. **P < 0.01. The authors apologize for this error.
Fields of Study & Subjects
Nanoplatforms for cancer theranostics
Selenium in Biological Systems
Curcumin's Biomedical Applications
Publication details
- Journal / source
- Dove Medical Press (Taylor and Francis Group)
- Publication date
- 7 February 2026
- Language
- EN